technical paper

ENDO 2020

Virtual, United States

Efficacy and Safety of Higher Dulaglutide Doses (3.0 MG and 4.5 MG) When Added to Metformin in Patients With Type 2 Diabetes: A Phase 3, Randomized, Double-Blind, Parallel ARM Study (Award-11)

Please log in to leave a comment

Next from ENDO 2020

technical paper

Innovations in Treatments: Device- and Drug-Based Approaches for Management of T1D

ENDO 2020

Lori Laffel

10 June 2020

Similar lecture

technical paper

Introduction to Novel Neuropeptides in Reproductive Axis Regulation

ENDO 2021

21 March 2021

Stay up to date with the latest Underline news!


  • All Lectures
  • For Librarians
  • Resource Center
  • Free Trial
Underline Science, Inc.
1216 Broadway, 2nd Floor, New York, NY 10001, USA

© 2023 Underline - All rights reserved